ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

DCPC Planning 10 More Prevention Fellowship Awards

August 14, 1987

In Brief: BRCA 2 Gene sequence Published; CALGB To Mark 40th Anniversary

March 8, 1996

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010

“Hop” May Include 100-200 Hospitals, Funded At Total Of $10 Million A Year, Should Start In FY 1982; DeVita

June 19, 1981

Study Finds Physician Referral By Centers Fraught With Problems, Potential Dangers

July 23, 1976